These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 7540470)

  • 1. CD34+ cell expansion and expression of lineage markers during liquid culture of human progenitor cells.
    Warren MK; Rose WL; Beall LD; Cone J
    Stem Cells; 1995 Mar; 13(2):167-74. PubMed ID: 7540470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new culture and quantitation system for megakaryocyte growth using cord blood CD34+ cells and the GPIIb/IIIa marker.
    Warren MK; Guertin M; Rudzinski I; Seidman MM
    Exp Hematol; 1993 Oct; 21(11):1473-9. PubMed ID: 7691635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
    Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cytokines on CD34+ Rh-123high and low progenitor cells from human umbilical cord blood.
    Cicuttini FM; Welch KL; Boyd AW
    Exp Hematol; 1994 Dec; 22(13):1244-51. PubMed ID: 7525327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive proliferative capacity of single isolated CD34 human cord blood cells in suspension culture.
    Xiao M; Broxmeyer HE; Horie M; Grigsby S; Lu L
    Blood Cells; 1994; 20(2-3):455-66; discussion 466-7. PubMed ID: 7538351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
    Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
    Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow.
    Smith SL; Bender JG; Maples PB; Unverzagt K; Schilling M; Lum L; Williams S; Van Epps DE
    Exp Hematol; 1993 Jul; 21(7):870-7. PubMed ID: 7686502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion of cord blood progenitors and use for hemopoietic reconstitution.
    Gabutti V; Timeus F; Ramenghi U; Crescenzio N; Marranca D; Miniero R; Cornaglia G; Bagnara GP
    Stem Cells; 1993 Jul; 11 Suppl 2():105-12. PubMed ID: 7691315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of human umbilical cord blood CD34+ hematopoietic progenitor cells with recombinant growth factors.
    Akabutu JJ; Chan JR
    Prog Clin Biol Res; 1994; 389():399-404. PubMed ID: 7535448
    [No Abstract]   [Full Text] [Related]  

  • 13. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
    Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
    Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
    Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy among erythropoietin, interleukin 3, stem cell factor (c-kit ligand) and interferon-gamma on early human hematopoiesis.
    Kawano Y; Takaue Y; Hirao A; Sato J; Abe T; Suzue T; Saito S; Okamoto Y; Kuroda Y
    Stem Cells; 1994 Sep; 12(5):514-20. PubMed ID: 7528591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors.
    Gore SD; Amin S; Weng LJ; Civin CI
    Exp Hematol; 1995 May; 23(5):413-21. PubMed ID: 7536683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro.
    Migliaccio G; Migliaccio AR; Druzin ML; Giardina PJ; Zsebo KM; Adamson JW
    J Cell Physiol; 1991 Sep; 148(3):503-9. PubMed ID: 1717499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of retroviral-mediated gene transduction of both the recombinant human erythropoietin receptor and interleukin-9 receptor genes into single CD34++CD33-or low cord blood cells on cytokine-stimulated erythroid colony formation.
    Lu L; Ge Y; Li ZH; Xiao M; Broxmeyer HE
    Exp Hematol; 1996 Feb; 24(2):347-51. PubMed ID: 8641364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of functional myeloid cells from CD34-selected hematopoietic progenitor cells using a clinically relevant ex vivo expansion system.
    Lill MC; Lynch M; Fraser JK; Chung GY; Schiller G; Glaspy JA; Souza L; Baldwin GC; Gasson JC
    Stem Cells; 1994 Nov; 12(6):626-37. PubMed ID: 7533581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.